Assenagon Asset Management S.A. Makes New $719,000 Investment in Eastman Chemical (NYSE:EMN)

Assenagon Asset Management S.A. acquired a new position in shares of Eastman Chemical (NYSE:EMNFree Report) in the first quarter, according to its most recent 13F filing with the Securities and Exchange Commission. The firm acquired 7,170 shares of the basic materials company’s stock, valued at approximately $719,000.

Other institutional investors have also recently bought and sold shares of the company. Norges Bank acquired a new stake in shares of Eastman Chemical during the 4th quarter valued at about $121,847,000. Invesco Ltd. lifted its holdings in shares of Eastman Chemical by 37.4% during the 3rd quarter. Invesco Ltd. now owns 2,795,824 shares of the basic materials company’s stock valued at $214,496,000 after buying an additional 760,974 shares during the last quarter. Capital Research Global Investors acquired a new stake in shares of Eastman Chemical during the 4th quarter valued at about $54,047,000. Mackenzie Financial Corp lifted its holdings in shares of Eastman Chemical by 274.5% during the 4th quarter. Mackenzie Financial Corp now owns 249,104 shares of the basic materials company’s stock valued at $22,375,000 after buying an additional 391,848 shares during the last quarter. Finally, Schonfeld Strategic Advisors LLC lifted its holdings in Eastman Chemical by 1,031.0% in the 3rd quarter. Schonfeld Strategic Advisors LLC now owns 333,655 shares of the basic materials company’s stock worth $25,598,000 after purchasing an additional 304,155 shares during the last quarter. 83.65% of the stock is currently owned by institutional investors and hedge funds.

Eastman Chemical Stock Performance

Shares of EMN traded down $0.55 on Wednesday, reaching $99.40. 522,688 shares of the stock traded hands, compared to its average volume of 1,032,773. The firm has a market cap of $11.69 billion, a price-to-earnings ratio of 12.81, a P/E/G ratio of 1.09 and a beta of 1.54. The company has a debt-to-equity ratio of 0.77, a current ratio of 1.39 and a quick ratio of 0.71. Eastman Chemical has a 12 month low of $68.89 and a 12 month high of $102.71. The stock’s 50-day moving average price is $98.07 and its 200-day moving average price is $89.78.

Eastman Chemical (NYSE:EMNGet Free Report) last released its quarterly earnings data on Thursday, April 25th. The basic materials company reported $1.61 earnings per share (EPS) for the quarter, beating analysts’ consensus estimates of $1.41 by $0.20. The business had revenue of $2.31 billion for the quarter, compared to analysts’ expectations of $2.29 billion. Eastman Chemical had a return on equity of 13.84% and a net margin of 10.16%. Eastman Chemical’s quarterly revenue was down 4.2% on a year-over-year basis. During the same period in the previous year, the business posted $1.63 earnings per share. Equities analysts forecast that Eastman Chemical will post 7.75 EPS for the current fiscal year.

Eastman Chemical Dividend Announcement

The business also recently declared a quarterly dividend, which will be paid on Tuesday, July 9th. Shareholders of record on Monday, June 17th will be given a $0.81 dividend. This represents a $3.24 dividend on an annualized basis and a yield of 3.26%. The ex-dividend date is Monday, June 17th. Eastman Chemical’s dividend payout ratio (DPR) is 41.75%.

Insider Buying and Selling at Eastman Chemical

In other Eastman Chemical news, SVP Adrian James Holt sold 4,735 shares of the company’s stock in a transaction on Wednesday, March 6th. The stock was sold at an average price of $87.75, for a total value of $415,496.25. The sale was disclosed in a legal filing with the SEC, which is available through the SEC website. In other Eastman Chemical news, SVP Adrian James Holt sold 4,735 shares of the business’s stock in a transaction on Wednesday, March 6th. The stock was sold at an average price of $87.75, for a total value of $415,496.25. The transaction was disclosed in a document filed with the SEC, which is available at this link. Also, CEO Mark J. Costa sold 102,390 shares of the business’s stock in a transaction on Tuesday, May 7th. The stock was sold at an average price of $100.78, for a total value of $10,318,864.20. Following the completion of the transaction, the chief executive officer now directly owns 395,699 shares in the company, valued at approximately $39,878,545.22. The disclosure for this sale can be found here. Insiders have sold 110,787 shares of company stock worth $11,105,175 over the last three months. Company insiders own 2.28% of the company’s stock.

Analyst Upgrades and Downgrades

Several research firms recently weighed in on EMN. Royal Bank of Canada boosted their target price on Eastman Chemical from $100.00 to $104.00 and gave the stock a “sector perform” rating in a report on Tuesday, April 30th. Wells Fargo & Company boosted their target price on Eastman Chemical from $89.00 to $100.00 and gave the stock an “equal weight” rating in a report on Thursday, April 11th. Mizuho boosted their target price on Eastman Chemical from $91.00 to $102.00 and gave the stock a “neutral” rating in a report on Friday, April 26th. KeyCorp boosted their target price on Eastman Chemical from $101.00 to $121.00 and gave the stock an “overweight” rating in a report on Tuesday, April 9th. Finally, Piper Sandler lifted their price target on Eastman Chemical from $90.00 to $105.00 and gave the stock a “neutral” rating in a research report on Tuesday, April 30th. Seven equities research analysts have rated the stock with a hold rating and ten have assigned a buy rating to the company’s stock. According to MarketBeat.com, the company has a consensus rating of “Moderate Buy” and an average target price of $104.18.

Read Our Latest Report on EMN

About Eastman Chemical

(Free Report)

Eastman Chemical Company operates as a specialty materials company in the United States, China, and internationally. The company's Additives & Functional Products segment offers amine derivative-based building blocks, intermediates for surfactants, metam-based soil fumigants, and organic acid-based solutions; specialty coalescent and solvents, paint additives, and specialty polymers; and heat transfer and aviation fluids.

Read More

Want to see what other hedge funds are holding EMN? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Eastman Chemical (NYSE:EMNFree Report).

Institutional Ownership by Quarter for Eastman Chemical (NYSE:EMN)

Receive News & Ratings for Eastman Chemical Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Eastman Chemical and related companies with MarketBeat.com's FREE daily email newsletter.